Ravi K Birla

Title: Innovations by Ravi K Birla in Tissue Engineering and Cardiac Constructs

Introduction

Ravi K Birla is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the fields of tissue engineering and drug delivery. With a total of 2 patents, his work focuses on developing biocompatible materials and innovative methods for medical applications.

Latest Patents

Birla's latest patents include a polymer designed for tissue engineering applications and drug delivery. This biocompatible and biodegradable elastomeric polymer material comprises glycerol and dodecanedioic acid, with a molar ratio of glycerol to dodecanedioic acid ranging from about 5:1 to about 1:5. The methods for using this polymer involve providing a PGD elastomeric polymer with a 1:1 molar ratio of glycerol to dodecanedioic acid and administering it to soft tissue defect sites. Another notable patent is a system and method for forming a cardiac muscle construct. This system includes a substrate and cardiac cells cultured in vitro without a scaffold, allowing the cells to become confluent and detach from the substrate to create a three-dimensional cardiac muscle construct.

Career Highlights

Ravi K Birla is affiliated with the University of Michigan, where he continues to advance research in his field. His innovative work has garnered attention and respect within the scientific community.

Collaborations

Birla has collaborated with notable colleagues, including Robert G Dennis and Marvin O Boluyl. Their combined expertise contributes to the success of their research endeavors.

Conclusion

Ravi K Birla's contributions to tissue engineering and cardiac constructs highlight his innovative spirit and dedication to advancing medical technology. His patents reflect a commitment to improving healthcare through scientific research and development.